Thursday, July 30, 2015 8:05:48 AM
They are trying to use the Lympro PRs to boost the pps. Why not try to use the Georgetown test which is better? Granted they do not own it yet, but well, that will be more likely to bring in cash than Lympro.
GC and company have been trying to move the pps with lympro and it never works because it cannot work. Even if you have someone else doing the talking.
Now, the ESS should bring in cash but they will have to give it away for the most part. It only takes one, if you can make enough money from it.
The truth is incontrovertible. Malice may attack it, ignorance may deride it, but in the end, there it is.
Winston Churchill
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM